Davis's Drug Guide : FDA Safety Information and Adverse Event Reporting

FDA Safety Information and Adverse Event Reporting
Tygacil (tigecycline): Label Change - Increased Mortality Risk
Huber Needles: Recall - Risk of Coring
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
TimeOut Capsules: Undeclared Drug Ingredient
MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient
Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
Mr. Magic Male Enhancer: Undeclared Drug Ingredient
INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow
Stalevo(carbidopa levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk
Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug
6 French Engage Introducer Devices by St. Jude Medical: Recall - Potential for Separation of Shaft From Hub
Prolatis': Undeclared Drug Ingredient
Lamictal (lamotrigine): Label Change - Risk of Aseptic Meningitis
Novacare LLC Products: Recall - Undeclared Drug Ingredient
Combat Application Tourniquets (C-A-T): Suspected Counterfeit Product
Inferior Vena Cava (IVC) Filters: Initial Communication: Risk of Adverse Events with Long Term Use
Solo Slim, Solo Slim Extra Strength: Recall - Undeclared Drug Ingredient
Revivexxx Extra Strength: Recall - Undeclared Drug Ingredient
Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions
Cook brand Ciaglia Blue Rhino Ciaglia Blue Dolphin Percutaneous Tracheostomy Introducer Sets and Trays

FDA Safety Information and Adverse Event Reporting

Tygacil (tigecycline): Label Change - Increased Mortality Risk

Description

September 01, 2010
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Web Link

FDA Safety Information and Adverse Event Reporting is a sample topic found in FDA MedWatch. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other FDA MedWatch topics, please login or purchase a subscription.

Top

FDA Safety Information and Adverse Event Reporting

Next >>

Content Manager: Search Unbound MEDLINE; Display all Sections; Font Size; Print Section Topic